Search

Author/Creator Chua, Laiyi

1. [P1–042]: PLASMA PHARMACOKINETICS AND PHARMACODYNAMICS OF SOLANEZUMAB IN MILD AND MODERATE AD PATIENTS. (1st July 2017)

Authors:
Willis, Brian A.; Ferguson‐Sells, Lisa R.; Chua, Laiyi; Siemers, Eric R.; Dean, Robert A.; Lachno, David Richard; Carlson, Christopher D.; Hake, Ann Marie; Hoffmann, Vicki P.; Friedrich, Stuart W.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects. Issue 12 (19th August 2021)

Authors:
Liu, Hui; Wang, Feng; Ji, Yongjia; Ma, Tianyang; Li, Hongying; Linnebjerg, Helle; Chua, Laiyi; Tham, Lai San; Yu, Yerong
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 12(2021)
Page Start:
1452
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus. Issue 1 (8th September 2016)

Authors:
Linnebjerg, Helle; Lam, Eric Chen Quin; Zhang, Xin; Seger, Mary E.; Coutant, David; Chua, Laiyi; Kapitza, Christoph; Heise, Tim
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 1(2017)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Exposure‐Response Modeling to Characterize the Relationship Between Ixekizumab Serum Drug Concentrations and Efficacy Responses at Week 12 in Patients With Moderate to Severe Plaque Psoriasis. (7th June 2018)

Authors:
Chigutsa, Emmanuel; Velez de Mendizabal, Nieves; Chua, Laiyi; Heathman, Michael; Friedrich, Stuart; Jackson, Kimberley; Reich, Kristian
Journal:
Journal of clinical pharmacology
Issue:
Volume 58:Number 11(2018)
Page Start:
1489
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels. Issue 6 (21st September 2017)

Authors:
Zhang, Xin; Lam, Eric Chen Quin; Seger, Mary E.; Coutant, David; Chua, Laiyi; Tan, Lai Hock; Soon, Danny; Linnebjerg, Helle
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 6(2017)
Page Start:
556
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. O1‐09‐01: SIGNIFICANT AND SUSTAINED FLORBETAPIR F18 UPTAKE REDUCTION IN PATIENTS WITH SYMPTOMATIC ALZHEIMER'S DISEASE WITH LY3002813, A β‐AMYLOID PLAQUE‐SPECIFIC ANTIBODY. (1st July 2006)

Authors:
Fleisher, Adam S.; Lowe, Stephen L.; Liu, Peng; Shcherbinin, Sergey; Li, Li; Chua, Laiyi; Nakano, Masako; Hawdon, Anne; Willis, Brian A.; Schwarz, Adam J.; Demattos, Ronald B.; Mintun, Mark A.; Irizarry, Michael C.
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7S(2018)Part 4
Page Start:
P239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Population pharmacokinetic and exposure–efficacy analysis of ixekizumab in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS). Issue 3 (2nd September 2021)

Authors:
Jackson, Kimberley; Chua, Laiyi; Velez de Mendizabal, Nieves; Pitou, Celine; Rodriguez Capriles, Claudia; Paller, Amy S.; Lansang, Perla; Seyger, Marieke M. B.; Papp, Kim
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 3(2022)
Page Start:
1074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗